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Atrial fibrillation (AF) is the most common form of arrhythmia, and it is associated with 
increased mortality and morbidity.1)2) AF significantly increases the risk for thromboembolic 
events, heart failure, hospitalization, and death. Ischemic stroke is the major cause of 
disability associated with AF. Therefore, various risk stratification strategies have been 
developed to quantify stroke risk in patients with AF and to guide strategies for clinicians 
to prevent the disability. The most widely used scoring system for risk estimation has 
been the CHADS2 score, which calculates risks based on the presence of congestive heart 
failure, hypertension, age 75 years or greater, diabetes mellitus, and prior stroke or transient 
ischemic attack. A revision of the CHADS2 score, which dichotomizes age and incorporates 
vascular disease and female sex, has been developed to create the CHA2DS2-VASc score; this 
score enhanced predictability among individuals with the lowest risk for AF.3)
Each factor of the CHA2DS2-VASc score represents the risk factor for ischemic stroke associated 
with AF. However, the mechanisms linking the clinical risk factors in CHA2DS2-VASc score 
to ischemic stroke have been incompletely defined. Most of the thrombi associated with 
AF originate in the left atrial appendage (LAA), and systemic embolization in AF usually 
originates from the LAA thrombi. Therefore, the contribution of clinical factors to ischemic 
stroke could be mediated by left atrium (LA) enlargement, which is largely associated with 
increase in LA pressure and LAA thrombosis. Traditionally, LA volume index has been 
known to be a morphologic expression of the severity and duration of left ventricular (LV) 
diastolic dysfunction. When LV filling pressure is elevated owing to diastolic dysfunction, 
LA enlargement may occur as a compensatory mechanism to maintain LA stroke volume, 
according to Frank–Starling's law.4) The clinical risk factors included in the CHA2DS2-
VASc score, such as hypertension, diabetes, old age, congestive heart failure, and vascular 
pathology, can directly or indirectly influence LV diastolic function. Thus, the linkage between 
clinical risk factors and LAA thrombi may be mediated by LV diastolic dysfunction, which 
could affect the size and pressure of the left atrium/LAA.
In this issue of the journal, Jang et al.5) investigated the association between CHA2DS2-VASc 
score and echocardiographic LV structural/functional parameters in consecutive 4,795 
J Cardiovasc Imaging. 2018 Sep;26(3):144-146
https://doi.org/10.4250/jcvi.2018.26.e14
pISSN 2586-7210·eISSN 2586-7296
Editorial
Received: Aug 23, 2018
Accepted: Sep 4, 2018
Address for Correspondence:
In-Jeong Cho, MD
Division of Cardiology, Severance 
Cardiovascular Hospital, Yonsei University 
College of Medicine, 50-1 Yonsei-ro, 
Seodaemun-gu, Seoul 03722, Korea.
E-mail: injeongcho@yuhs.ac
Copyright © 2018 Korean Society of 
Echocardiography
This is an Open Access article distributed 
under the terms of the Creative Commons 
Attribution Non-Commercial License (https://
creativecommons.org/licenses/by-nc/4.0/) 
which permits unrestricted non-commercial 
use, distribution, and reproduction in any 
medium, provided the original work is properly 
cited.
ORCID iDs
In-Jeong Cho 
https://orcid.org/0000-0002-1209-5129
Conflict of Interest
The author have no financial conflicts of 
interest.
In-Jeong Cho , MD 
 Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, 
Korea
Left Ventricular Diastolic Function: 
The Link between CHA2DS2-VASc Score 
and Ischemic Stroke in Patients with 
Atrial Fibrillation
► See the article “Cardiac structural or functional changes associated with CHA2DS2-VASc scores in 
nonvalvular atrial fibrillation: a cross-sectional study using echocardiography” in volume 26 on 
page 135.
patients with nonvalvular AF. The authors showed that increasing CHA2DS2-VASc scores were 
associated with a high LV mass index, LA volume index, and E/E′, suggesting its association 
with diastolic dysfunction and increased LV filling pressure or LA pressure. E/E′, a ratio of 
early mitral inflow to mitral annulus velocity during early diastole, is known to be a reliable 
echocardiographic marker for LV filling pressure, and it is even applicable to patients with AF. 
While septal E/E′ ≥11 suggests elevated LV filling pressure in AF,6) the mean value of E/E′ in 
the group of patients with CHA2DS2-VASc score 2–3 was 13; the value proportionally increased 
with increase in the CHA2DS2-VASc score, suggesting a stepwise increase in the LV filling 
pressure as the CHA2DS2-VASc score rises. The authors also showed that LA volume index 
continuously increased following the increase in CHA2DS2-VASc score, while its stepwise 
increase in the LA dimension at the anteroposterior direction was blunted in patients 
with CHA2DS2-VASc score more than 2. Herein, we can reconfirm the usefulness of the LA 
volume index over simple LA dimension in the assessment of LV diastolic function and LV 
filling pressure. The authors suggested that the underlying mechanism for this correlation 
is mediated by LV diastolic dysfunction, which is associated with clustering of demographic 
factors constituting the CHA2DS2-VASc score. Therefore, we can speculate that the cascade 
of LV diastolic dysfunction, LA enlargement, LA dysfunction, and finally LA thrombosis7) is a 
plausible explanation for ischemic stroke in patients with high CHA2DS2-VASc score.
Current management of AF is mainly focused on the prevention of ischemic stroke with 
anticoagulation. However, congestive heart failure is an important disease observed in 
patients with AF, and patients with AF have 3 times more chances than normal individuals 
do, of developing congestive heart failure.8) However, only limited data are available to help 
identify patients with AF who are at an increased risk for heart failure, whereas risk factors 
for stroke have been extensively evaluated, leading to the development of the CHA2DS2-VASc 
scoring systems to identify patients who might benefit from more intense anticoagulation 
therapy. The present study provides new therapeutic challenges on the management of 
AF by revealing the mechanisms of high CHA2DS2-VASc score causing ischemic stroke. 
The authors suggested that lowering the LV filling pressure can be a therapeutic target for 
nonvalvular AF with a high CHA2DS2-VASc score. However, data supporting this hypothesis 
are limited. Outcome data showing the prognostic implications of CHA2DS2-VASc score for 
diastolic heart failure are warranted. Management strategies other than anticoagulation 
warrant further investigation in patients with a high CHA2DS2-VASc score. In other words, 
the role of therapies that lower LV filling pressure through diuretics or vasodilators in 
patients with a high CHA2DS2-VASc score should be investigated further to secure the 
authors' hypothesis of the concomitant presence of high LA pressure in patients with a 
high CHA2DS2-VASc score. The exact association between CHA2DS2-VASc score and cardiac 
structure/function and the optimal method to improve outcomes in patients with AF remain 
to be determined.
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